KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 82 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,300 | -25.1% | 6,194 | 0.0% | 0.00% | – |
| Q2 2023 | $11,087 | -54.0% | 6,194 | 0.0% | 0.00% | -100.0% |
| Q1 2023 | $24,095 | +19.7% | 6,194 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $20,131 | -39.0% | 6,194 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $33,000 | +22.2% | 6,194 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $27,000 | -41.3% | 6,194 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $46,000 | +15.0% | 6,194 | 0.0% | 0.00% | +100.0% |
| Q4 2021 | $40,000 | +11.1% | 6,194 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $36,000 | -43.8% | 6,194 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $64,000 | -1.5% | 6,194 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $65,000 | -32.3% | 6,194 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $96,000 | +6.7% | 6,194 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $90,000 | -23.1% | 6,194 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $117,000 | +13.6% | 6,194 | +16.0% | 0.01% | 0.0% |
| Q1 2020 | $103,000 | +9.6% | 5,338 | +9.3% | 0.01% | +50.0% |
| Q4 2019 | $94,000 | +100.0% | 4,886 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $47,000 | +95.8% | 4,886 | +21.6% | 0.00% | +100.0% |
| Q2 2019 | $24,000 | +4.3% | 4,019 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $23,000 | -39.5% | 4,019 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $38,000 | -44.1% | 4,019 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $68,000 | 0.0% | 4,019 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $68,000 | +70.0% | 4,019 | +35.5% | 0.00% | +50.0% |
| Q1 2018 | $40,000 | +42.9% | 2,967 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $28,000 | -6.7% | 2,967 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $30,000 | +11.1% | 2,967 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $27,000 | +17.4% | 2,967 | +66.5% | 0.00% | 0.0% |
| Q1 2017 | $23,000 | – | 1,782 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |